Tamoxifen 10 - Livewell Pharmaceuticals

First synthesized by ICI in the early 1960s, Tamoxifen citrate began as an experimental contraceptive compound. Although it failed in that role, its potent anti-estrogenic activity led to new applications in cancer therapy. It was approved in 1977 under the name Nolvadex and became a cornerstone drug in the management of hormone-sensitive breast cancer. Later, Tamoxifen found additional use in the fitness and bodybuilding communities for managing estrogen levels after anabolic steroid cycles, where it remains an essential selective estrogen receptor modulator (SERM).

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tamoxifen 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.